Back

C-Reactive Protein to Albumin Ratio offers superior risk prediction in patients undergoing mitral valve edge-to-edge repair: a comparison to established surgical risk scores

28 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Mitral valve regurgitation: predicting outcomes of intervention Mitral Valve Regurgitation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Benedikt Koell

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

7 More presentations in this session

Presentation thumbnail
Man-machine interaction-based phenotyping identifies pathophysiologically and prognostically informative clusters among patients with mitral regurgitation undergoing transcatheter edge-to-edge repair
Doctor M. Lachmann (Munich, DE)
Abstract Slides
Presentation thumbnail
Echocardiography and computed tomography predictors of successful transcatheter direct annuloplasty for mitral regurgitation
Doctor C. Iliadis (Cologne, DE)
Abstract Slides
Presentation thumbnail
Single centre experience in transcatheter mitral valve implantation: valve in valve, valve in ring and valve in MAC
Doctor H. Alvarez Covarrubias (Munich, DE)
Abstract Slides
Presentation thumbnail
Impact of proportionate versus disproportionate mitral regurgitation on acute procedural changes and clinical outcomes following transcatheter mitral valve repair
Doctor E. Kronzer (Rochester, US)
Abstract Slides
Presentation thumbnail
Impact of percutaneous mitral valve clipping on right ventricular functions
Professor O. Rifaie (Cairo, EG)
Abstract Slides

Access the full session

Session thumbnail
Mitral valve regurgitation: predicting outcomes of intervention

The Event

Event poster

ESC Congress 2022

28 August 2022 11:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources